1 results
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Daliresp (Roflumilast ... tablet once daily ... recommendations for the treatment ... won’t have any clinical ... /ambcarerx #Daliresp